Similar articles for PMID: 21980038

Year	Number of Results
1993	1
1994	1
1996	1
1999	1
2000	2
2001	5
2003	2
2005	8
2006	4
2007	5
2008	5
2009	5
2010	6
2011	8
2012	1
2013	2
2014	2
2016	1
2017	1
2024	0

1

Aberrant expression of chromogranin A, miR-146a, and miR-146b-5p in prostate structures with focally disrupted basal cell layers: an early sign of invasion and hormone-refractory cancer?

Man YG, Fu SW, Liu AJ, Stojadinovic A, Izadjoo MJ, Chen L, Gardner WA. Man YG, et al. Cancer Genomics Proteomics. 2011 Sep-Oct;8(5):235-44. Cancer Genomics Proteomics. 2011. PMID: 21980038

2

Focal degeneration of basal cells and the resultant auto-immunoreactions: a novel mechanism for prostate tumor progression and invasion.

Man YG, Gardner WA. Man YG, et al. Med Hypotheses. 2008;70(2):387-408. doi: 10.1016/j.mehy.2007.05.015. Epub 2007 Jul 20. Med Hypotheses. 2008. PMID: 17658698

3

Cell clusters overlying focally disrupted mammary myoepithelial cell layers and adjacent cells within the same duct display different immunohistochemical and genetic features: implications for tumor progression and invasion.

Man YG, Tai L, Barner R, Vang R, Saenger JS, Shekitka KM, Bratthauer GL, Wheeler DT, Liang CY, Vinh TN, Strauss BL. Man YG, et al. Breast Cancer Res. 2003;5(6):R231-41. doi: 10.1186/bcr653. Epub 2003 Oct 3. Breast Cancer Res. 2003. PMID: 14580259 Free PMC article.

4

Differential impact of tumor-infiltrating immune cells on basal and luminal cells: implications for tumor invasion and metastasis.

Song G, Hsiao H, Wang JL, Mannion C, Stojadinovic A, Avital I, Fu SW, Mason J, Chen W, Jewett A, Li H, Man YG. Song G, et al. Anticancer Res. 2014 Nov;34(11):6363-80. Anticancer Res. 2014. PMID: 25368236

5

The prognostic role of immunohistochemical chromogranin a expression in prostate cancer patients is significantly modified by androgen-deprivation therapy.

Berruti A, Bollito E, Cracco CM, Volante M, Ciccone G, Porpiglia F, Papotti M, Scarpa RM, Dogliotti L. Berruti A, et al. Prostate. 2010 May 15;70(7):718-26. doi: 10.1002/pros.21104. Prostate. 2010. PMID: 20087896

6

Focal prostate basal cell layer disruptions and leukocyte infiltration are correlated events: A potential mechanism for basal cell layer disruptions and tumor invasion.

Man YG, Shen T, Zhao Y, Amy Sang QX. Man YG, et al. Cancer Detect Prev. 2005;29(2):161-9. doi: 10.1016/j.cdp.2005.01.004. Cancer Detect Prev. 2005. PMID: 15829376

7

MicroRNA profiles of healthy basal and luminal mammary epithelial cells are distinct and reflected in different breast cancer subtypes.

Bockmeyer CL, Christgen M, Müller M, Fischer S, Ahrens P, Länger F, Kreipe H, Lehmann U. Bockmeyer CL, et al. Breast Cancer Res Treat. 2011 Dec;130(3):735-45. doi: 10.1007/s10549-010-1303-3. Epub 2011 Mar 17. Breast Cancer Res Treat. 2011. PMID: 21409395

8

Immunohistochemical study of chromogranin A in Stage D2 prostate cancer.

Kokubo H, Yamada Y, Nishio Y, Fukatsu H, Honda N, Nakagawa A, Saga S, Tsuzuki T, Hara K. Kokubo H, et al. Urology. 2005 Jul;66(1):135-40. doi: 10.1016/j.urology.2005.01.026. Urology. 2005. PMID: 15992907

9

[Plasma chromogranin-A (CgA)--a potential marker for diagnosis, monitoring and management of prostate cancer patients].

Leibovitch I, Pinthus Y, Sella BA, Ramon J. Leibovitch I, et al. Harefuah. 2006 Jan;145(1):25-9, 78. Harefuah. 2006. PMID: 16450720 Hebrew.

10

Independent prognostic role of circulating chromogranin A in prostate cancer patients with hormone-refractory disease.

Berruti A, Mosca A, Tucci M, Terrone C, Torta M, Tarabuzzi R, Russo L, Cracco C, Bollito E, Scarpa RM, Angeli A, Dogliotti L. Berruti A, et al. Endocr Relat Cancer. 2005 Mar;12(1):109-17. doi: 10.1677/erc.1.00876. Endocr Relat Cancer. 2005. PMID: 15788643

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

58 results

Results by year